DOMH · Dominari Holdings Inc.
$2.65
-0.07 (-2.57%)
At close · Jul 24
Market Cap
$59.70M
Shares
22.61M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Kyle Wool | President | $2,838,735 |
| Anthony Hayes | CEO | $2,776,692 |
| Soo Yu | Special Projects Manager | $2,414,222 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Soo Yu | Special Projects Manager | $8,305,915 |
| Special Projects Manager | — | $8,305,915 |
| Anthony Hayes | CEO | $1,000,000 |
| Kyle Wool | President | $600,360 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Anthony Hayes | CEO | $1,693,350 |
| Carlos Aldavero | President | $629,589 |
| Darrell Dotson | VP of Drug Development & General Counsel | $317,308 |
| Christopher Devall | Chief Operating Officer | $272,601 |
| Kyle Wool | President | — |
| Special Projects Manager | — | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Anthony Hayes | CEO | $960,000 |
| Darrell Dotson | VP of Drug Development & General Counsel | $325,000 |
| Christopher Devall | Chief Operating Officer | — |
| Carlos Aldavero | President | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Anthony Hayes | CEO | $1,122,251 |
| Darrell Dotson | General Counsel | $318,750 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Anthony Hayes | CEO | $350,000 |